Healthcare trends

    Americas IBS Treatment Market Scenario Irritable bowel syndrome (IBS) is a common ailment that affects the large intestine. Symptoms of IBS include cramping, abdominal pain, bloating, gas, diarrhea and constipation. Diagnosis of irritable bowel syndrome is done by tests such as blood tests, stool tests, endoscopic procedures and external imaging procedures whereas the treatment includes relieving the patient from the symptoms and improving the quality of life. The Americas IBS treatment market is expected to grow at a CAGR of 9.3% during the forecast period 2017-2023. The major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period. Increasing prevalence of gastrointestinal diseases and disorder, unhealthy diet, anxiety, and changing lifestyle in Americas also fuel this market. According to statistics published by the U.S. Food and Drug Administration (FDA), irritable bowel syndro

    MRFR is the Leading Brand in The Research Company who Recently Published Global Thoracic outlet syndrome Market Research Reports which includes Study of Growth Overview, Regional Analysis, Top Players, Major Drivers, Upcoming Trends and Foreseen to 2023. Market Highlights: It is estimated that thoracic outlet syndrome market is expected to grow at a CAGR 7.0% during the forecast period of 2017-2023. Thoracic outlet syndrome is the compression of the neurovascular structures caused due to weight lifting, tumors in the chest, bone abnormalities, trauma, and others. A number of factors such as rising cases of road traffic injuries, increasing cases of anatomical defects, high unmet needs of current treatment, and surge in the research and development expenditure, improvement in reimbursement policies are propelling the growth of the global thoracic outlet syndrome market. However, difficult diagnosis, lack of infrastructure in the middle and low-income countries, and side effects asso

    Market Scenario The lazy eye disease or amblyopia is a childhood condition affecting the development of vision. In this disease, it the brain does not acknowledge the images seen by the eye. The condition affects only one of the eye but can further result in the impairment of vision in the other eye. Increasing prevalence of the lazy eye diseases and growing child population are the major drivers for the market growth during the forecast period. According to the National Health Service, U.K, 1 in every 50 children is predicted to develop a lazy eye. Moreover, in 2016, it was reported that there were approximately 4014.3 million children within the U.K. Additionally, rising healthcare expenditures and increasing R&D by the major market players fuel the market growth. However, lack of awareness and unavailability of the effective treatment procedures may restrain the market growth during the forecast period.   View Reports Sample @  https://www.marketresearchfuture.com/sample_req

    Market Highlights: Liver biopsy is a diagnostic procedure for liver diseases, recommended when blood tests or diagnostic imaging might suggest a liver problem. It is of three major types namely percutaneous, transjugular, and laparoscopic. It is also used to monitor the liver condition during liver transplant and to determine complications if any. The healthcare provider may recommend liver biopsy if the patient is diagnosed with liver disease or identifies the presence of blood in the urine. As per the Health Survey for England 2014, Hepatitis B is one of the world’s most common liver infection in the world, affecting huge population across the globe. Increasing awareness about early diagnosis of liver diseases and upsurge in demand for technologically advanced medical devices for diagnosis and treatment of chronic diseases including liver failure drive the global liver biopsy market . The global liver biopsy market is expected to grow at a CAGR of ~4.2% during the forecast perio

    Global Healthcare Ediscovery Market Research Report Analysis By Deployment (On-Premise System and Cloud System), Application (Audit Trail Via Metadata, Communication, Ehr-Hosting), End-Users (Healthcare It Companies, Hospitals, Clinics, Pharmacy) – Forecast till 2023 Healthcare Ediscovery Market Overview: Healthcare industry depends much on the better performance of the litigious system; strong adherence to that provides seamless workflow. But this requires a lot of backing from proper archiving of data, which the industry has realized recently. Proper filing, channeling, and easy integration of the IoT are expected to provide better expansion scope to the global healthcare eDiscovery market. The healthcare eDiscovery market is eyeing for a 11.5% CAGR during the forecast period (2017-2023). Market Research Future (MRFR) in its recent study of the market revealed that the market has strong potential to outpace its predictive state in the coming years Several features in the global h

  MarketResearchFuture.com Present a Universal Study Research Report “Protein Microarray Market Research Report – Global Forecast till 2023” This Report aim is Provide Insights about Factors Affecting the Market Growth and also Future Growth. Protein Microarray Market – Competitive Landscape The Key Players in Protein Microarray Market include SEQUENOM, Inc. (U.S.), Agilent Technologies (U.S.), Illumina Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Affymetrix, Inc. (U.S.), Abbott Laboratories (U.S.), Sigma Aldrich Corporation (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific (U.S), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Medtronic Inc. (U.S.), EMD Millipore (U.S.), Angioscore Ltd. (U.S.), and F. Hoffmann-La Roche AG (Genentech) (Switzerland). Get Exclusive Sample Copy at https://www.marketresearchfuture.com/sample_request/5310 Protein Microarray Market- Overview Protein microarray, also known as protein chips are an emerging class of proteomic t

    Market Statistics Market Research Future (MRFR) observed that the growing number of invalids, bearing lactose intolerance can surge the global lactose intolerance treatment market. MRFR reckoned that global lactose intolerance treatment market to be valued at a considerable amount of USD 9.4 billion and is expected to capitalize with a CAGR of 7.2% between 2017 and 2023. Market Insights The need for better remedies for treating lactose intolerant patients is observed to be a strong driver for the global lactose intolerance treatment market growth. Although, there is no specific drug to cure the disorder, the high availability of alternative food items for milk and enzymatic lactase supplements are likely to spur the lactose intolerance treatment market growth. Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3868 This, brings in the great contributions the market players have to make. These giant companies, surge the rate of production of eatables that pro

  Medical Smart Textile Market anticipated to garner a CAGR of 9.5% during the forecast period 2019 To 2027. Soaring Demand for Monitoring Devices to Encourage Global Medical Smart Textile Market. For this study Medical Smart Textile Market is segmentd by Technology (Smart Fabric Technology, Textile Sensors, Wearable Technology), Application (Surgery, Hygiene, Drug-Release System, Bio-Monitoring), End-User (Hospitals, Clinics, Others), and Region with forecast to 2027. The players dominating the global medical smart textile market includes Intelligent Clothing Ltd. (UK), Google Inc. (US), Textronics, Inc. (US), International Fashion Machines (US), Sensoria Inc. (US), Interactivewear (Germany), Vista Medical Ltd. (Canada), Schoeller Textiles AG (Switzerland), Gentherm (US), and others. Get Free Sample “Global Medical Smart Textile Market 2019 Report” at:  https://www.marketresearchfuture.com/sample_request/1123 Global Medical Smart Textile Market Overview: The global medical smart texti

    Global Glioblastoma Market Size, Trends and Share Analysis by Type (Primary Glioblastoma and Secondary Glioblastoma), by Treatment (Surgical Procedure, Radiation Therapy, Chemotherapy), by End User (Hospitals, Specialty Clinics & Centers) and Region, Forecast to 2025 Glioblastoma Market Analysis By Size, Share, Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2025 Glioblastoma Market Highlights Glioblastoma Market Segment Analysis: The Global Glioblastoma Market size is expected to register a CAGR of 7.40% during the forecast period with a market value of USD 1,643.4 Million till 2025. Glioblastoma is a malignant grade IV tumor. The increasing incidence rates, the rise in product approvals, and growing research in the field are projected to drive the growth of the global glioblastoma market. On the other hand, the termination of many clinical trial drug candidates is anticipated to hamper the growth of the market. The global g

  Market Highlights The Global Stoma or Ostomy Care Market is estimated to be valued at USD 4,109.11 Million by 2024 and is expected to register a CAGR of 7.2% during the forecast period. The global stoma or ostomy care market has been segmented by type into two-piece system and one-piece system. The two-piece system segment is holding the largest market share of 55.6% in 2018 of global stoma or ostomy care market, by type, and is projected to reach USD 2,266.86 million by 2024 , as it is user-friendly, durable, and convenient for changing the bag without removing the skin barrier from the stoma. America dominated the market, accounting for the largest share of the market by 43.3% in 2017. The European market was the second-largest in 2017 valued at USD 578.53 million . The European market is forecasted to register a CAGR of 7.2% by the end of 2024 , with Germany being the leading regional market. Market Players Market Research Future (MRFR) recognizes Coloplast Corp. (Denmark), Co